Gavin Roddy is an Ophthalmology physician affiliated with Mayo Clinic. OpenAlex indexes 63 publications with 1,121 citations (h-index 14).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
200 1st St SW
Rochester, MN 559050001
Telephone
507-284-2511Provider last certified this registry record 8 Jan 2021.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Sight Sciences, Inc.Program year20241 payment
- Glaukos CorporationProgram year20241 payment
- ABBVIE INC.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
74.2%Corticosteroid17.4%Prednisolone Acetate100%Part D≥87 patientsCarbonic Anhydrase Inhibitor16.5%Dorzolamide-Timolol74%Dorzolamide Hcl26%Part D≥43 patients+ 3 more classes in this area
Anti-infectives
14.2%Fluoroquinolone Antibacterial14.2%Moxifloxacin100%Part D≥82 patientsMusculoskeletal
7.2%Cyclooxygenase Inhibitor7.2%Ketorolac Tromethamine100%Part D≥47 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2021–2026 per NIH RePORTER. The latest:
- Characterization and treatment of a novel model of radiation optic neuropathy using the tree shrew
Mayo Clinic Rochester
FY2026$121,171R21CA286349 - Virally expressed Stanniocalcin-1 for long-term intraocular pressure reduction
Mayo Clinic Rochester
FY2025$155,597K08EY031758 - Characterization and treatment of a novel model of radiation optic neuropathy using the tree shrew
Mayo Clinic Rochester
FY2025$67,465R21CA286349
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Impact of Metabolic Syndrome on Cataracts: A Systematic Review and Meta-Analysis
Metabolic Syndrome and Related Disorders
2026 - Evaluation of AI Summaries on Interdisciplinary Understanding of Ophthalmology Notes
JAMA Ophthalmology
2025 - Optimizing procedures for ocular radiation injury studies in the tree shrew
Exploration of Targeted Anti-tumor Therapy
2025
Similar KOLs
Other experts from the same institution or the same specialty.
S Rajkumar, MD
Mayo Clinic
Bradley Boeve, MD
Mayo Clinic
Rick Nishimura, MD
Mayo Clinic
Victor Montori, MD
Mayo Clinic
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”